Skip to content

BELESSENTIAL: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BELESSENTIAL

BE 1001.518.565
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€253
2024 · -€706+€452
Equity
€868
2024 · €1,121-€253
Cash
€359
2024 · €1,598-€1,239
Balance sheet total
€2,839
2024 · €4,201-€1,362

Largest movements

2024 to 2025
Assets
  • Cash -€1,239

    down €1,239 (-77.5%), from €1,598 to €359

    mainly Other debts (-€963) and Net result for the year (-€253)

  • Stocks and contracts -€198

    down €198 (-7.6%), from €2,604 to €2,406

  • Receivables within one year +€74

    new in 2025: €74

Equity and liabilities
  • Other debts -€963

    down €963 (-32.8%), from €2,934 to €1,971

  • Profit (loss) carried forward -€253

    down €253 (-13.5%), from -€1,879 to -€2,132

  • Tax, wage and social debts -€112

    no longer reported in 2025 (was €112)

Income statement
  • Other operating charges -€475

    down €475 (-95.0%), from €500 to €25

  • Financial charges +€72

    up €72 (+138.8%), from €52 to €125

  • Gross operating margin +€55

    up €55 (+34.7%), from -€158 to -€103

  • Financial income -€5

    down €5 (-99.8%), from €5 to €0

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€706
Gross operating margin +€55
Other operating charges +€475
Financial income -€5
Financial charges -€72
Result 2025 -€253

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€1,239
Investment €0
Financing €0
Cash 2024 €1,598
Net result for the year -€253
Stocks and contracts +€198
Receivables within one year -€74
Trade debts -€35
Tax, wage and social debts -€112
Other debts -€963
Cash 2025 €359
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,201 €2,839 -€1,362 -32.4%
Current assets 29/58 €4,201 €2,839 -€1,362 -32.4%
Stocks and contracts in progress 3 €2,604 €2,406 -€198 -7.6%
Stocks 30/36 €2,604 €2,406 -€198 -7.6%
Amounts receivable within one year 40/41 - €74 +€74
Other amounts receivable 41 - €74 +€74
Cash at bank and in hand 54/58 €1,598 €359 -€1,239 -77.5%
Total equity and liabilities 10/49 €4,201 €2,839 -€1,362 -32.4%
Equity 10/15 €1,121 €868 -€253 -22.6%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 -€1,879 -€2,132 -€253 -13.5%
Amounts payable 17/49 €3,080 €1,971 -€1,109 -36.0%
Amounts payable within one year 42/48 €3,080 €1,971 -€1,109 -36.0%
Trade debts 44 €35 - -€35
Suppliers 440/4 €35 - -€35
Taxes, remuneration and social security 45 €112 - -€112
Taxes 450/3 €112 - -€112
Other amounts payable 47/48 €2,934 €1,971 -€963 -32.8%
Other operating charges 640/8 €500 €25 -€475 -95.0%
Gross operating margin 9900 -€158 -€103 +€55 +34.7%
Operating profit (loss) 9901 -€658 -€128 +€530 +80.5%
Financial income 75/76B €5 €0 -€5 -99.8%
Recurring financial income 75 €5 €0 -€5 -99.8%
Financial charges 65/66B €52 €125 +€72 +138.8%
Recurring financial charges 65 €52 €125 +€72 +138.8%
Profit (loss) for the period before taxes 9903 -€706 -€253 +€452 +64.1%
Profit (loss) for the period 9904 -€706 -€253 +€452 +64.1%
Profit (loss) for the period to be appropriated 9905 -€706 -€253 +€452 +64.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.